Migraines & headaches Board decisions

The Board denied an increased rating for migraines and chronic sinusitis, as the evidence did not show very frequent completely prostrating and prolonged attacks productive of severe economic inadaptability for migraines or three or more incapacitating episodes per year for chronic sinusitis.

The Board remands the claims for an increased rating for hypertensive heart disease with syncopal episodes, TDIU, service connection for a bowel and/or bladder disability, and service connection for headaches to afford the Veteran another opportunity for VA examinations.

The Veteran is granted special monthly compensation based on the need for regular aid and attendance due to his service-connected disabilities.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection.

The Board denied an initial rating in excess of 30 percent for the Veteran's migraine headaches, finding that the disability most nearly approximated characteristic prostrating attacks occurring on an average of once a month.

The Board remands the claims for service connection for migraine headaches, bilateral pes planus, and bilateral plantar fasciitis to obtain a more adequate medical opinion addressing direct and secondary service connection.

The Board remands the Veteran's claim for service connection for headaches to cure a pre-decisional duty to assist error.

The Board granted a 70 percent rating for generalized anxiety disorder with major depressive disorder as of August 10, 2022, but denied a higher rating prior to that date. The claim for migraine headaches was denied.

The Board denied service connection for bilateral foot condition, hypertension, and a compensable evaluation for migraine prior to May 15, 2023. However, the effective date of January 21, 2016 for the award of a total disability rating based on individual unemployability was granted.

The Board granted an initial 10 percent rating for headaches based on the evidence showing characteristic prostrating attacks averaging one in two months over a period of several months.

The Board granted service connection for headaches, to include migraine headaches, resolving all doubt in the Veteran's favor.

The appeal for service connection for psoriatic arthritis, a back disability, and a migraine disability was dismissed as untimely filed. The claim for a rating in excess of 30 percent for scarring from psoriasis and the claim for a rating in excess of 60 percent for psoriasis with residual scars were denied.

The Board granted an initial disability rating of 30 percent for tension headaches but denied a higher rating and an increased rating in excess of 10 percent for gastroesophageal reflux disease (GERD).

The Board remands the claims for obstructive sleep apnea and tension headaches to obtain additional medical opinions regarding their etiology, including whether they are caused or aggravated by service-connected conditions.

The Board remands the claim for service connection of migraines as secondary to insomnia due to an inadequate VA medical opinion.

The Board dismissed the claim for service connection for migraines and denied the claim for bilateral hearing loss. The claims for eczema of the hands, a psychiatric disorder, left knee disorder, and right knee disorder were remanded for further development.

The Board denied separate compensable ratings for a seizure disorder and migraine headaches associated with the Veteran's service-connected traumatic brain injury (TBI) residuals.

The Veteran withdrew the appeal for service connection for migraines, and the Board has no further jurisdiction to review this issue.

The Board granted a September 14, 2021, effective date for a 50 percent rating for headaches based on the Veteran's lay statement and medical records showing frequent prostrating attacks.

The Board denied earlier effective dates for the grants of service connection for migraines, hypertension, and atrial fibrillation, as well as a compensable rating for hypertension.